Concepedia

Yuta Myojin

YM

Statistics

Publications

22

Citations

999

H-Index

15

Active since

2019

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

The University of Osaka

National Institutes of Health

Ikeda Municipal Hospital

Yuta Myojin is an author at National Cancer Institute specializing in oncology, medicine, and cancer immunotherapy.

ORCID

Publications per year

2019–2025

22

Publications

22

Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production

Yuta Myojin, Hayato Hikita, Masaya Sugiyama et al. · Gastroenterology · 2020 · 197 citations · Full text

, , +17

Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin

Benjamin Ruf, Matthias Bruhns, Sepideh Babaei et al. · Cell · 2023 · 173 citations · Full text

, , +16

Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy

Yuta Myojin, Takahiro Kodama, Ryotaro Sakamori et al. · Cancers · 2022 · 84 citations · Full text

, , +17

ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma

Yuta Myojin, Takahiro Kodama, Kazuki Maesaka et al. · Clinical Cancer Research · 2020 · 73 citations · Full text

, , +17

Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer

Cecilia Monge, Changqing Xie, Yuta Myojin et al. · Journal for ImmunoTherapy of Cancer · 2023 · 71 citations · Full text

, , +17

1–5 of 22